The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice

Autor: Forny Germano, Leticia, Koehler, Jacqueline A., Baggio, Laurie L., Cui, Fiona, Wong, Chi Kin, Rittig, Nikolaj, Cao, Xiemin, Matthews, Dianne, Drucker, Daniel J.
Zdroj: In Molecular Metabolism November 2024 89
Databáze: ScienceDirect